Barcelona, Spain, 11 February 2026
Medichem Solutions S.L.,subsidiary of Medichem announces a strategic collaboration with Breckenridge Pharmaceutical, Inc. (“Breckenridge”) a U.S.-based generic pharmaceutical company and subsidiary of Towa International.
The collaboration covers a portfolio of injectable products for hospital and specialty use, including anesthesia, critical care, and emergency medicine. Under the agreement, Medichem Solutions S.L., Medichem’s wholly owned subsidiary, will develop and manufacture selected products at its new state-of-the-art sterile fill-and-finish facility in Asturias, Spain, supporting supply to the U.S. market.
By combining Medichem’s advanced development and manufacturing expertise with Breckenridge’s strong presence in the U.S. hospital channel, the collaboration is designed to support the delivery of high-quality, affordable injectable medicines. In addition to manufacturing, Medichem will contribute its regulatory and technical expertise, including in assisting Breckenridge in the preparation, filing and prosecution of the ANDA dossier for the U.S. market, ensuring an integrated approach from development through commercialization.
“We are very pleased to collaborate with Breckenridge on some of the first products to be manufactured at our new sterile facility,” said Olga Urazova, Chief Commercial Officer of Medichem. “This partnership reflects our shared focus on quality, reliability, and long-term collaboration, and highlights Medichem’s ability to support partners across development, manufacturing, and regulatory activities.”
The collaboration highlights Medichem’s strengthened capabilities in sterile injectable development, manufacturing and global regulatory support – areas of increasing demand as pharmaceutical companies seek flexible, experienced partners capable of advancing products from concept through dossier submission and approval.
About Medichem Solutions S.L.
Medichem Solutions S.L. (Asturias, Spain), a wholly owned subsidiary of Medichem, operates a new, state-of-the-art sterile fill-and-finish facility that strengthens Medichem’s B2B platform and supports partners across hospital and specialty markets. Medichem, headquartered in Barcelona, Spain, is a vertically integrated pharmaceutical company focused on the development and manufacture of high-quality APIs and Drug Products for the global generics industry. With a commitment to quality, reliability and operational excellence, Medichem partners with pharmaceutical companies worldwide to support the expansion of their portfolios and the delivery of affordable medicines to patients.
For more information, please visit: www.medichem.es
About Breckenridge Pharmaceutical, Inc.:
Breckenridge Pharmaceutical, Inc. (New Jersey), the U.S. subsidiary of Towa International (Barcelona, Spain), partners with manufacturers nationwide and around the world to bring quality, cost-effective generic pharmaceuticals to U.S. patients. With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we strive to impact the health of the patients we and our customers serve.
